Aim ImmunotechAIM
13F holders, Q4 2025 (December 31)13holders −2
1new positions
4sold out
$1.13avg. 13F price*
At the end of Q4 2025, 13 institutions reported holding Aim Immunotech Inc. (AIM) in their 13F filings, down 2 from Q3 2025. 1 opened new positions and 4 sold out. The largest holders were DRW Securities, LLC ($79K), Vanguard Group Inc. ($20K) and Geode Capital Management, LLC ($20K).
- Company
- Aim Immunotech Inc.
- CUSIP
- 00901B303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $141 |
| Exits | 4 | $79K |
All 13F filers, Q3 2025 → Q4 2025: 27,646 shares bought and 28,919 shares sold, net −1,273 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| DRW Securities, LLC | 0.01% | Add +60.6% | 69,545 | $79K |
| Vanguard Group Inc. | 0.00% | No change | 17,502 | $20K |
| Geode Capital Management, LLC | 0.00% | Add +7.3% | 17,376 | $20K |
| Morgan Stanley | 0.00% | Add +0.1% | 864 | $976 |
| UBS Group AG | 0.00% | Add +24.7% | 379 | $428 |
| Community Bank, N.A. | 0.00% | No change | 132 | $147 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 125 | $141 |
| Bank of America Corp. | 0.00% | Add +3.7% | 28 | $32 |
| Osaic Holdings, Inc. | 0.00% | No change | 15 | $16 |
| Hoey Investments, Inc. | 0.00% | No change | 10 | $12 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 2 | $2 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1 | $1 |
| Intesa Sanpaolo Wealth Management | 0.00% | — | 1 | $1 |
"% of holder's portfolio" is AIM's weight in each manager's 13F, not the share of Aim Immunotech Inc. the manager owns.